Page 45 - Contract Development News Today

/PRNewswire/ -- As per Facts and Factors study, The global Peptide Synthesis market size was estimated to be worth roughly USD 509.74 million in 2021 and is...

Italian medical devices and pharmaceutical products exports to the UAE have risen 63% to 76 million euros ($82.71 million) between January and September 2022.

30.01.2023 - PolyPeptide / Key word(s): Personnel PolyPeptide: CEO of PolyPeptide resigns 30-Jan-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Media Release ...

/PRNewswire/ -- The "North America Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial...

Contract development and manufacturing organization (CDMO) that provide services for processing large molecule or biologics drug substances are referred to...

First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy - read this article along with other careers information, tips and advice on BioSpace

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has decided to increase its GMP*1 manufacturing capacity for mRNA*2 in Kaneka Eurogentec S.A. (Headquarters:

Stelis Biopharma Ltd has received Establishment Inspection Report from the USFDA specific to Drug-Device Combination Products to be commercialized at Stelis flagship facility in Bengaluru, India.

The Series C deal, upon closing, would dilute GenScript Biotech's stake in Probio Cayman.

/PRNewswire/ -- The companies certified as 2023 Top Employers have just been announced and Hovione has been recognised as Top Employer in Portugal, the United...